Trigeminal Neuralgia Archives - Neurology Advisor

Demyelinating Plaques: A Cause of Trigeminal Neuralgia Secondary to MS

By

Brandon May

February 2, 2021

Study researchers investigated whether neurovascular contact with morphological changes influences the etiology of trigeminal neuralgia secondary to MS.

Pain

Trigeminal Neuralgia: Differential Diagnosis and Treatment Strategies

By

Amber Pratt, PA-S

Lisa Daitch, MPAS, PA-C

February 1, 2021

Trigeminal neuralgia is a chronic neuropathic pain disorder that is important to include in the differential diagnosis of head or facial pain.

Multiple Sclerosis

Study Characterizes Treatment and Prognostic Factors Associated With MS Related Trigeminal Neuralgia

By

Brandon May

May 22, 2020

Researchers sought to collect information on the characteristics of MS-related TN and on the frequency and type of medical/surgical treatments.

Neuropathy

Somatosensory and Psychosocial Changes Related to Trigeminal Nerve Damage

By

Amit Akirov, MD

May 8, 2020

Researchers to explore the somatosensory changes related to trigeminal nerve damage using psychophysical and electrophysiological tools.

Pain

Nerve Volumes Predict Surgical Outcome in Patients With Trigeminal Neuralgia

By

Brandon May

January 13, 2020

Larger contralateral trigeminal nerve and hippocampus volumes are predictive of early nonresponse to surgical treatment of trigeminal neuralgia.

Neuropathy

Pulsed Radiofrequency May Relieve Trigeminal Postherpetic Neuralgia Pain

By

Gary Rothbard

August 30, 2019

Computed tomography-guided pulsed radiofrequency therapy may offer pain relief, improve quality of life, and reduce medication use in patients with trigeminal postherpetic neuralgia.

Migraine and Headache

OnabotulinumtoxinA Injection of Sphenopalatine Ganglion May Not Improve Trigeminal Neuralgia

By

Hannah Dellabella

August 22, 2019

The injection of onabotulinumtoxinA toward the sphenopalatine ganglion in patients with trigeminal neuralgia may not reduce the number of attacks.

General Neurology

FDA: Company Promoting Unapproved Stem Cell Products for ALS, Parkinson Disease and Other Serious Conditions

By

Brian Park, PharmD

June 5, 2019

The FDA has sent an untitled letter to R3 Stem Cell, LLC of Scottsdale, Arizona for marketing unapproved stem cell products to treat a variety of diseases and conditions.